In this podcast, Prof. Matthew Popplewell, lead investigator, discusses the BASIL-3 RCT, diving into the trial's design, the recruitment challenges, the statistical power, and the relevance of its findings to current clinical practice. The discussion also touches on the demographics of the patient population involved in the trial, the underrepresentation of women in vascular trials, the mortality toll of these patients, the recurrent nature of chronic limb-threatening ischemia and the implications for generalizability of the results. Unmissable!

Read the full text- article open access through this link:

https://www.bmj.com/content/bmj/388/bmj-2024-080881.full.pdf

And check out the companion BASIL Prospective ...